2,3‐bis((4‐(Pyridin‐2‐yl)‐1H‐1,2,3‐Triazol‐1‐yl)methyl) Quinoxaline Based Cyclometalated Binuclear Ir (III) Complex for Photodynamic Therapy in Triple Negative Breast Cancer Cell
Chemistry – An Asian Journal · 2025
DOI: 10.1002/asia.202401047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2025. Verfasst von Sreelekha U und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, Tamilnadu. Hauptthemen laut MEDLINE: Iridium, Photochemotherapy, Triple Negative Breast Neoplasms, Quinoxalines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: 'VIT SEED GRANT', DST-FIST, Department of Science and Technology.
Abstract (Originalsprache)
Herein, we have developed a novel 2,3‐bis ((4‐(pyridin‐2‐yl)‐1H‐1,2,3‐triazol‐1‐yl) methyl) quinoxaline based binuclear cyclometalated Iridium (III) complex ( CIr 2 L ) for TNBC treatment. The complex has high protein binding affinity ( K HSA =0.362×10 6 M −1 ) and high DNA binding affinity ( K b =0.92×10 6 M −1 ). The complex exhibited best efficiency as a Type II PDT agent due to its ability to induce 1 O 2 generation. The low dark cytotoxicity, high phototoxicity (IC 50 =2.3±0.8 μM, PI=31.3) and selectivity (selectivity factor>50‐fold over normal HEK‐293 cells) of complex CIr 2 L in MDA‐MB‐231 TNBC cell line makes it well‐suited for PDT. The DCFDA comparison study conducted in MDA‐MB‐231 cells under light and dark conditions demonstrated significant ROS generation with light exposure. JC‐1 staining revealed a substantial disruption in mitochondrial membrane potential (MMP). The mechanism of cell death was evaluated using an annexin V‐FITC/PI flow cytometric assay, confirming a higher percentage of early apoptotic cells under light exposure. Mechanistically, this type of electropositive binuclear complex is being selectively transported to cancer cell membrane through serum albumin and depleted the GSH level by the generation of ROS in presence of light leading to DNA photocleavage followed by apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, 632014, Tamilnadu.
ORCID-Profile: Priyankar Paira
Förderung
- 'VIT SEED GRANT'
- DST-FIST
- Department of Science and Technology
- DST-SERB CRG
- Dipartimento di Scienze e Tecnologie, Università degli Studi del Sannio
Zitieren
APA
U, S., & Paira, P. (2025). 2,3‐bis((4‐(Pyridin‐2‐yl)‐1H‐1,2,3‐Triazol‐1‐yl)methyl) Quinoxaline Based Cyclometalated Binuclear Ir (III) Complex for Photodynamic Therapy in Triple Negative Breast Cancer Cell. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202401047
Vancouver
U S, Paira P. 2,3‐bis((4‐(Pyridin‐2‐yl)‐1H‐1,2,3‐Triazol‐1‐yl)methyl) Quinoxaline Based Cyclometalated Binuclear Ir (III) Complex for Photodynamic Therapy in Triple Negative Breast Cancer Cell. Chemistry – An Asian Journal. 2025. doi:10.1002/asia.202401047
BibTeX
@article{U2025,
author = {U, Sreelekha and Paira, Priyankar},
title = {2,3‐bis((4‐(Pyridin‐2‐yl)‐1H‐1,2,3‐Triazol‐1‐yl)methyl) Quinoxaline Based Cyclometalated Binuclear Ir (III) Complex for Photodynamic Therapy in Triple Negative Breast Cancer Cell},
journal = {Chemistry – An Asian Journal},
year = {2025},
doi = {10.1002/asia.202401047}
}
EUVIMED